Being responsive to the ever-changing needs of the pharmaceutical market is an essential consideration for a company like Aktana. Our value proposition has always been the right information, in the right place, at the right time—a moving target that we must constantly pay attention to and adjust for in order to reach. There’s simply no […]

How can we improve the way physicians and pharmaceutical companies work together? That’s the challenge posed by Align Biopharma—a new collaboration between our partner Veeva and some of the world’s leading life science companies including Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis and Pfizer. In a recent article, FiercePharma explains how this new group is making it […]

July 27, 2016/Aktana/Decision Support

We recently had the privilege of attending Veeva’s Commercial Summit in China, perhaps the world’s most significant pharmaceutical market. As home to the largest potential patient market and the greatest number of unique pharmaceutical manufacturers, China presents no shortage of opportunities. Plus, with more people involved in pharma commercialization in China than any other single country, […]

April 28, 2016/Aktana/Decision Support

We’re proud to announce that Gartner, one of the world’s leading independent information technology research and advisory firms, has identified Aktana as a “Cool Vendor” in Life Sciences for 2016. Each year, the firm recognizes five pioneering vendors per field that stand out as innovators in their respective industries, and we’re honored to be included. […]

As multi-channel marketing becomes more prevalent in the pharmaceutical industry, so does talk of making the sales representative the point person for multi-channel touches. The most common analogy I’ve heard is the rep being the “quarterback” of their territory. They are given a playbook, but make the calls at the line based off of their […]

September 8, 2015/Derek Choy/Decision Support

Today we arrive at the final part of our Six-Part Decision Support series. So far, we have reviewed the five key tenets of decision support design and the four most common categories of use cases. But even the best designed decision support program can fail to deliver results if it is not implemented well. Below […]

As we continue to review the common use cases faced by pharmaceutical companies regarding rep decision support, we move from the categories of Execution and Impact, which we covered in Part 4 of our series, to Agility and Coordination. Agility “The only constant in life is change.” It’s unlikely that the Greek philosopher Heraclitus had […]

Welcome back to the Decision Support Series! Today we move on from “best practices in DSE Design” to “common use cases.” Understanding these cases helps companies looking to get started with Decision Support tailor their initiatives towards specific challenges or outcomes that are most relevant to their business. The use cases we’ve seen most frequently […]

In this six-part blog series, we’ve been sharing best practices for Decision Support design, application and implementation. In Decision Support Part 1 and Decision Support Part 2 we covered the first three of our five key design tenets for Decision Support. Today we’ll cover the last two: Less is More. Make it Real. Keep it Current. […]

We began this six-part blog series last week, with the goal of sharing best practices for Decision Support design, application and implementation.  In Part 1 of the Decision Support series, I described the journey we traveled to land on 5 key tenets of Decision Support design and then explained why ‘Less is More’.  As a […]